# Study of LAU-7b in the Treatment of Cystic Fibrosis in Adults

> **NCT03265288** · PHASE2 · COMPLETED · sponsor: **Laurent Pharmaceuticals Inc.** · enrollment: 166 (actual)

## Conditions studied

- Cystic Fibrosis

## Interventions

- **DRUG:** LAU-7b
- **DRUG:** Placebo oral capsule

## Key facts

- **NCT ID:** NCT03265288
- **Lead sponsor:** Laurent Pharmaceuticals Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-11-05
- **Primary completion:** 2021-09-15
- **Final completion:** 2021-09-15
- **Target enrollment:** 166 (ACTUAL)
- **Last updated:** 2024-10-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03265288

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03265288, "Study of LAU-7b in the Treatment of Cystic Fibrosis in Adults". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03265288. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*